Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$88.72
0.250.28%
At close: -
$88.72
0.000.00%
After Hours: Mar 21, 4:00 PM EDT
Comments
Loading...
Blueprint Medicines (BPMC) Forecast
NewsEarningsBlueprint Medicines (BPMC) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Blueprint Medicines Stock Price, Quotes and Forecasts | NASDAQ:BPMC | Benzinga
Explore Blueprint Medicines stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for BPMC.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Blueprint Medicines (BPMC) stock?
You can purchase shares of Blueprint Medicines (NASDAQ:BPMC) through any online brokerage.
Who are Blueprint Medicines (BPMC) competitors?
Other companies in Blueprint Medicines’s space includes: Legend Biotech (NASDAQ:LEGN), Avidity Biosciences (NASDAQ:RNA), Ultragenyx Pharmaceutical (NASDAQ:RARE), Exact Sciences (NASDAQ:EXAS) and Sarepta Therapeutics (NASDAQ:SRPT).
What is the forecast, or price target, for Blueprint Medicines (BPMC) stock?
Blueprint Medicines has a consensus price target of $118.12.
What is the current price for Blueprint Medicines (BPMC)?
The stock price for Blueprint Medicines (NASDAQ: BPMC) is $88.72 last updated March 21, 2025 at 4:00 PM EDT.
Does Blueprint Medicines (BPMC) pay a dividend?
There are no upcoming dividends for Blueprint Medicines.
When is Blueprint Medicines (NASDAQ:BPMC) reporting earnings?
Blueprint Medicines’s Q1 earnings are confirmed for Thursday, May 1, 2025.
Is Blueprint Medicines (BPMC) going to split?
There is no upcoming split for Blueprint Medicines.
What sector and industry does Blueprint Medicines (BPMC) operate in?
Blueprint Medicines is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.